Nano, Marmie R.
HRN: 09-56-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
CEFUROXIME 1.5GM (VIAL)
08/13/2025
08/13/2025
IVT
1.5g
Ptor
Stat CS
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: